PS
Peter Scott Chin sold $37K of DNLI stock
Peter Scott Chin, Chief Medical Officer of Denali Therapeutics Inc. (DNLI), sold 1,654 shares of DNLI stock worth $37K, per an SEC Form 4 filed Sep 9, 2026.
It was an open-market sale.
The trade happened on Sep 4, 2026, 5 days before it was made public.
DNLI has moved -15.2% since the trade date, from $22.28 to $18.89 (Nov 12, 2026 close).
- Traded
- Sep 4, 2026
- Disclosed
- Sep 9, 2026
- Filing delay
- 5 days
- Price since
- -15.2%
- Role
- Chief Medical Officer
- Source
- SEC Form 4